Competing interest declarations and management

From Cancer Guidelines Wiki


Competing interest declarations and management

Working Party Members were asked to declare in writing, any interests relevant to the guideline development, prior to commencement. Members were asked to update their information if they became aware of any changes to their interests.

All declarations were added to a register of interests as listed below. The register was made available to the Working Party throughout the development of the guideline, allowing members to take any potential conflicts of interest into consideration during discussions, decision making and formulation of recommendations.

If Working Party Members were identified as having a significant real or perceived conflict of interest, the Chair could decide that the member either leave the discussion whilst the specific area they were conflicted in was discussed or the member could remain present but not participate in the discussion, or decision making on the specific area where they were conflicted. There were no instances where this occurred during the development of this guideline.

Guideline working party members are responsible to update their conflict of interest statements if a new interest arises. The members will receive a formal reminder to review their statements and ensure it is up-to-date prior to the yearly meetings that will be scheduled to review all updates.


Working party member Competing interest declaration
Angelique Levert No competing interest to declare.
Associate Professor Alan Moss MBBS (Hons) MD, FRACP No competing interest to declare.
Associate Professor Bernard Mark Smithers National Advisory Board for Novartis on the management of GIST. No payment received for this service at this time.
Associate Professor Christophe Rosty, MD PhD FRCPA No competing interest to declare.
Associate Professor Freddy Sitas No competing interest to declare.
Associate Professor Geoffrey Hebbard Has received Research Support, Travel Grants and sponsorship of educational activities from the manufacturers and local distributors of all PPIs, H2Receptor Antagonists and Prokinetics. Has had, but has no current consultancies with any of those companies.

Has received support for sponsorship of educational activities from medical device manufacturers with products relevant to the diagnosis and management of patients with Barrett’s Oesophagus. Has no shares or other financial links with the manufacturer or distributors of any of the relevant pharmaceutical or device manufacturing companies. Owns shares in The Gut Shop, a company that distributes equipment used in the assessment of patients with gastrooesophageal reflux disease, including patients with Barrett’s Oesophagus.

Associate Professor Guy Eslick No competing interest to declare.
Associate Professor Ian Norton MBBS, PhD, FRACP From 2008-2013 was a member of a steering committee for an Astra Zeneca sponsored educational meeting. Honorarium payment involved.

Currently member of Advisory Board for Olympus Australia.

Associate Professor Jurgen Stahl FRCPA No competing interest to declare.
Associate Professor Neil Walker MD, FRCPA No competing interest to declare.
Associate Professor Sarah J (Sally) Lord MBBS MSc(Applied Biostatistics and Epidemiology) Married to Working Party member Reginald Lord.
Clinical Professor Marian Priyanthi Kumarasinghe No competing interest to declare
David Whiteman No competing interest to declare.
Dr Adrian Chung MBBS, BMed Sci, FRACP No competing interest to declare.
Dr Andrew Clouston MBBS PhD FRCPA No competing interest to declare.
Dr Andrew Taylor MBBS MD FRACP No direct competing interest.

Previous recipient of Victorian State Department of Health New Technology Grant to establish endoscopic treatment programme for dysplastic Barrett’s oesophagus statewide programme at St Vincent’s Hospital and in conjunction with Prof Finlay Macrae, Royal Melbourne Hospital. This funding enabled purchase of Halo Radiofrequency Ablation equipment for three years 2009-2011. No specific further funding since then.

Dr Bradley Kendall MBBS, FRACP No competing interest to declare.
Dr Catherine Campbell MBBS, FRCPA No competing interest to declare.
Dr Darren A. Pavey MBBS FRACP No competing interest to declare.
Dr Eric Y Lee BSc(Med) MBBS Hons FRACP No competing interest to declare
Dr Farzan Fahrtash Bahin, MBBS (Hons), MPhil (Med) No competing interest to declare.
Dr Florian Grimpen, MD, FRACP No competing interest to declare.
Dr Henry To No competing interest to declare.
Dr Iain Thomson MBBS, FRACS No competing interest to declare.
Dr Ian Brown FRCPA No competing interest to declare.
Dr Ian Faud Yusoff MBBS, FRACP No competing interest to declare
Dr Jeremy Dwyer MBBS (Hons) No competing interest to declare.
Dr Louisa Gordon No competing interest to declare.
Dr Luke Hourigan MBBS FRACP Member of ANZELF research group and has received sponsorship to attend annual scientific meeting sponsored by Olympus Australia
Dr Mark Appleyard MD FRACP MRCP MBBS BSc Has received financial support from Olympus to attend educational conferences; equipment support for clinical research and financial support for clinical research staff.
Dr Mark Schoeman MBBS, PhD, FRACP, AGAF No competing interest to declare.
Dr Oliver Maximilian Fisher, MD Supported by a grant from the Swiss Cancer League (BIL KLS-3133-02-2013).
Dr Spiro Raftopoulos No competing interest to declare.
Dr Sutharshan Kannuthurai No competing interest to declare.
Dr W Bastiaan de Boer MBBS, BMedSci, FRCPA No competing interest to declare.
Dr Yuri Veniaminovich Bobryshev PhD No competing interest to declare
Erfan Jaberiyanfar No competing interest to declare.
Melissa Thomas No competing interest to declare.
Ms Qingwei Luo No competing interest to declare.
Peter Sarich No competing interest to declare.
Professor David Watson MBBS, MD, FRACS No competing interest to declare.
Professor James Kench No competing interest to declare.
Professor Jon Emery MA, MBBCh, FRACGP, MRCGP, DPhil Chief investigator on a research project investigating a non-endoscopic approach to screening for Barrett’s oesophagus in primary care. No pecuniary interest in the associated cytosponge screening test.
Professor Michael Bourke MBBS, FRACP No competing interest to declare.
Professor Prithi S Bhathal, MBBS PhD FRCPA No competing interest to declare.
Professor Rajvinder Singh MBBS MRCP MPhil FRACP AM FRCP No competing interest to declare.
Professor Reginald V Lord MBBS MD FRACS Married to Working Party member Sarah (Sally) Lord
Professor Shan Rajendra MBBCh, MSc, MRCP. MD, FRCP, FRCPE, FRACP Member of Medical Advisory Committee, GI Dynamics, Australia.
Sonali Munot No competing interest to declare.

Derek Maule - No competing interest to declare.